Oncocyte
Johnson joined Oncocyte Corporate in September 2021. Prior to joining Oncocyte, Johnson holds the Chief Technology Officer in Alveo Technologies, an IVD company focusing on development of cutting edge molecular diagnostic tests for Over The Counter (OTC) and Point-Of-Care (POC) applications. Johnson led the teams to develop the COVID-19 be.well Test for a successful US clinical trial and obtained the CE mark and UK approval.
This person is not in any offices
Oncocyte
Oncocyte’s mission is to provide tests to physicians and patients that provide answers at critical decision points during a lung cancer diagnosis.